TL;DR: Asukamycin (CAS 156317-47-4) is a chemical compound with molecular formula C31H34N2O7 and molecular weight 546.2366 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
7-cyclohexyl-N-[5-hydroxy-5-[7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
Also Known As: Asukamycin, Manumycin F, 7-Cyclohexyl-N-[5-hydroxy-5-[7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
| Molecular Formula | C31H34N2O7 |
| Molecular Weight | 546.2366 g/mol |
| XLogP | 3.5 |
| Topological Polar Surface Area (TPSA) | 145.0 Ų |
| Hydrogen Bond Donors | 4 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Exact Mass | 546.2366 Da |
| Heavy Atoms | 40 |
| Complexity | 1270.0 |
| SMILES | C1CCC(CC1)C=CC=CC=CC(=O)NC2=CC(C3C(C2=O)O3)(C=CC=CC=CC(=O)NC4=C(CCC4=O)O)O |
| InChIKey | SSHVAUUEPNULMP-UHFFFAOYSA-N |
The XLogP value of 3.5 indicates that Asukamycin is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 145.0 Ų indicates high polarity, suggesting Asukamycin may have limited membrane permeability but good aqueous solubility. Following Lipinski's Rule of Five, Asukamycin has 4 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
The CAS number of Asukamycin is 156317-47-4.
The molecular formula of Asukamycin is C31H34N2O7.
The molecular weight of Asukamycin is 546.2366 g/mol.
You can request a quote for Asukamycin directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for Asukamycin and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 156317-47-4. Our professional technical team will respond with pricing and lead time.